Inpegsomatropin clinical trials
How each study uses inpegsomatropin is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the inpegsomatropin studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your alerts, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your alerts. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Name
- Inpegsomatropin Injection
- 4
Studies by the year they started
4 studies that test it; most in 2026 (3)
| Year | Studies |
|---|---|
| 2025 | 1 |
| 2026 | 3 |
Who runs them
Industry 4 · Other 0
Studies
Open first, then newest update. How each study uses inpegsomatropin is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 4
- A Clinical Study of Long-Term Administration of Inpegsomatropin Injection in Participants With Idiopathic Short Stature Who Have Completed Phase Ⅲ Clinical TrialsRecruitingNot applicableXiamen Amoytop Biotech Co., Ltd.NCT07894341Written as Inpegsomatropin Injection
- Safety, Pharmacokinetic (PK) Profile and Efficacy of Inpegsomatropin Injection in Adults With Growth Hormone DeficiencyRecruitingPhase 2Xiamen Amoytop Biotech Co., Ltd.NCT07551804Written as Inpegsomatropin Injection
- The Efficacy and Safety of Inpegsomatropin Injection in Children With Short Stature Born Small for Gestational AgeRecruitingPhase 3Xiamen Amoytop Biotech Co., Ltd.NCT07309562Written as Inpegsomatropin Injection
- The Efficacy and Safety of Inpegsomatropin Injection in Children With Idiopathic Short StatureRecruitingPhase 3Xiamen Amoytop Biotech Co., Ltd.NCT06927310Written as Inpegsomatropin Injection
What changed recently
From the registry's own updates since Oct 18, 2026.
Codes
What other systems call inpegsomatropin · ClinicalTrials.gg INT017411
- UNII (FDA) NUB86ZJ8XTINPEGSOMATROPINOne source FDA
- NCI Thesaurus C199062InpegsomatropinOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| UNII (FDA) | NUB86ZJ8XT | INPEGSOMATROPIN | One source FDA |
| NCI Thesaurus | C199062 | Inpegsomatropin | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.